| Â | Â | ACTUAL TREATMENT |
|---|
AASLD INDICATIONS | Â | RESECTION | OLTx | PEI/RFTA | TACE | BSC |
|---|
| Â | RESECTION |
5 (13%)
| 1(2%) | 24(59%) | 10(24%) | 1(2%) |
| Â | OLTx | 2(33%) |
2(33%)
| - | 2(33%) | - |
| Â | PEI or RFTA | 1(7%) | - |
6(46%)
| 4(31%) | 2(16%) |
- OLTx: orthotopic liver transplantation; RFTA: radiofrequency-mediated thermal ablation;
- PEI: percutaneous ethanol injection; TACE: transcatheter arterial chemoembolization; BSC: best supportive care
- AASLD indications for treatment are reported in rows; percentages of patients treated per each modality are calculated on the totality of patients having that specific indication.
- The adherence to AASLD indication was evaluated when all data were available (60/65 pts – 91%).
